Fact CheckerSign in

NCT07853898Recruiting

Effects of Pistachios on Postprandial Metabolic Responses in Adults With Overweight or Obesity

Acute Effects of Pistachio Consumption on Postprandial Metabolic Responses in Adults With Overweight or Obesity: A Randomized Controlled Crossover Trial

Source: ClinicalTrials.gov · Last updated 2 Oct 2026

Brief summary (registry, in English)

This randomized controlled crossover study will examine the acute effects of pistachio consumption on postprandial metabolic responses in adults with overweight or obesity. Participants will complete two experimental conditions in randomized order. In one condition, participants will consume 30 g of pistachios with a standardized meal, and in the other condition they will receive an isocaloric refined-carbohydrate control condition with the standardized meal. The study will evaluate postprandial insulin and glucose responses over approximately 3 hours after meal consumption. Additional outcomes will include continuous glucose monitoring measures, blood lipid responses, appetite and satiety ratings, and exploratory measures related to insulin sensitivity and gastrointestinal hormone responses. The study is designed to determine whether pistachio consumption alters acute metabolic responses compared with an isocaloric refined-carbohydrate control in adults with overweight or obesity.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
28 (estimated)
First submitted
26 Sept 2026
Start date
Oct 2026
Primary completion date
Jul 2027
Lead sponsor
St. Louis University
Diseases
Obesity
NCT number
NCT07853898

What you commit to

  • Study type: Interventional
  • Planned participants: 28
  • From Oct 2026 to the primary completion date, Jul 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Clinically significant cardiovascular disease, including prior myocardial infarction or stroke, uncontrolled hypertension, clinically significant arrhythmia, or another cardiovascular condition that could make participation unsafe or meaningfully affect study outcomes.
  • Current or prior clinically significant eating disorder that, in the investigator's judgment, could make participation unsafe or interfere with the feeding protocol.

Other illness

  • Known diagnosis of type 1 or type 2 diabetes. Individuals with known prediabetes will not be excluded.
  • Chronic kidney disease or another major medical condition that could make participation unsafe or meaningfully affect metabolic outcomes.
  • Current participation in a weight-loss program, use of weight-loss medications, or history of bariatric surgery within the past year.
  • Known allergy or intolerance to pistachios, tree nuts, peanuts/peanut butter, wheat/gluten, orange juice/citrus, or any other study-meal ingredient.
  • Celiac disease, Crohn's disease, ulcerative colitis, or another clinically significant gastrointestinal or malabsorption condition that could affect digestion, nutrient absorption, or metabolic responses.
  • Recent significant illness, infection, or surgery within the past 4 weeks that could affect participant safety or study outcomes.
  • Any condition or medication that, in the investigator's judgment, would make participation unsafe or interfere with outcome measures.

Other

  • Current ketogenic, very-low-carbohydrate, or medically prescribed diet that could meaningfully interfere with the standardized feeding protocol or metabolic outcomes.
  • Participation in another clinical research trial within the past 3 months that could affect participant safety or study outcomes.
  • Current smoking, frequent nicotine use, or excessive alcohol use.
  • Pregnancy, planned pregnancy during the study period, or lactation.

Who the study is looking for

  • Age 18-35 years, male or female, and able to provide informed consent.
  • BMI ≥25.0 kg/m². Waist circumference and BIA-derived body composition will also be assessed during screening and considered with BMI to help confirm that elevated BMI reflects excess adiposity rather than primarily high muscularity.
  • Weight stable, defined as no intentional weight loss or body weight change \>3 kg during the previous 3 months.
  • Generally healthy and not currently taking medications known to substantially affect glucose metabolism, insulin secretion, insulin sensitivity, appetite, or body weight. Stable thyroid hormone replacement for a well-controlled thyroid condition is not automatically exclusionary.
  • Able to complete a 10-12-hour overnight fast and refrain from vigorous exercise and alcohol for 24 hours before each test meal visit.
  • Able and willing to consume pistachios, the refined-carbohydrate control food, and the standardized breakfast meal.

Age in the registry: 18 years to 35 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Saint Louis University
Coordinator of this site? Confirm its status
St LouisUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.